| 主权项 |
1. A method of determining the concentration of a prostate cancer biomarker or affiliated molecular partner in a sample comprising:
(a) obtaining a sample from a subject; (b) treating said sample to digest one or more prostate cancer biomarkers or affiliated molecular partners contained therein; (c) generating a mass spectrometry profile of the digested sample of step (b); (d) comparing the mass spectrometry profile from step (c) to a standard curve, wherein said standard curve has been created using at least one calibration standard selected from the group consisting of SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 25, SEQ ID NO. 26, SEQ ID NO. 27, SEQ ID NO 28, SEQ ID NO. 29 SEQ ID NO. 30, SEQ ID NO. 31, SEQ ID NO. 32, SEQ ID NO. 33, SEQ ID NO. 34, SEQ ID NO. 35, SEQ ID NO. 36, SEQ ID NO. 37, SEQ ID NO. 38, SEQ ID NO. 39, SEQ ID NO. 40, SEQ ID NO. 41, SEQ ID NO. 42, SEQ ID NO. 43 and combinations thereof; and (e) calculating a concentration of said one or more prostate cancer biomarkers or affiliated molecular partners in the sample obtained from the subject based on the standard curve. |
